Eltrombopag for Inherited Thrombocytopenias
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Eltrombopag (Primary)
- Indications Congenital disorders; Platelet dysfunction
- Focus Therapeutic Use
- 16 Aug 2017 Planned primary completion date changed from 1 May 2017 to 1 Sep 2017.
- 28 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Apr 2015 Status changed from not yet recruiting to recruiting as reported by Clinical Trials.gov.